Suscribirse

Impact of Vax-a-Million Lottery on COVID-19 Vaccination Rates in Ohio - 17/11/21

Doi : 10.1016/j.amjmed.2021.06.032 
Neil K.R. Sehgal, BA
 Institute for Applied Computational Science, Harvard University, Cambridge, Massachusetts 

Requests for reprints should be addressed to Neil K. R. Sehgal, BA, Institute for Applied Computational Science, Harvard University, Cambridge, Massachusetts.Institute for Applied Computational ScienceHarvard UniversityCambridgeMassachusetts

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

A decrease in coronavirus disease 2019 (COVID-19) vaccination rates has led some states to consider various incentives to boost demand for vaccines. On May 13, 2021, Ohio announced a free weekly lottery for individuals who received at least 1 COVID-19 vaccination. This study seeks to rigorously quantify the impact of Ohio's vaccination lottery.

Methods

A synthetic control consisting of a weighted combination of other states was used to approximate the demographic characteristics, new cases, and vaccination rates in Ohio prior to the lottery announcement. The difference in vaccination rates in Ohio and the synthetic control following the lottery announcement was then used to estimate the lottery's impact.

Results

Prior to the lottery announcement, Ohio and synthetic Ohio had similar demographic characteristics and new case rates. Ohio and synthetic Ohio also had identical first vaccination rates. By the final lottery enrollment date of June 20, the percentage of the population with first vaccinations increased to 47.41% in Ohio and 46.43% in synthetic Ohio for a difference of 0.98% (95% confidence interval [CI] 0.42-1.54).

Conclusion

An additional 114,553 Ohioans received vaccinations as a result of the Vax-a-Million program (95% CI 49,094-180,012) at a cost of approximately $49 per Ohioan vaccinated (95% CI $31-$114). However, a majority of Ohioans remained unvaccinated by the end of the lottery, indicating that additional efforts are needed to address barriers to vaccination. This synthetic control approach may also be useful to evaluate other COVID-19 incentive programs.

El texto completo de este artículo está disponible en PDF.

Keywords : COVID-19, Lottery, Incentive, Synthetic control method, Vaccination


Esquema


 Funding: None.
 Conflicts of Interest: None.
 Authorship: The author is solely responsible for the content of this manuscript.


© 2021  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 134 - N° 11

P. 1424-1426 - novembre 2021 Regresar al número
Artículo precedente Artículo precedente
  • Body Weight and Future Risk of Pneumonia
  • Atsuyuki Watanabe
| Artículo siguiente Artículo siguiente
  • AAIM Principles and Recommendations for the 2021-2022 Internal Medicine Residency Interview Cycle in Response to the Continued COVID-19 Pandemic
  • Jaya M. Raj, Cindy J. Lai, Stacy Higgins, Katherine C. Chretien, Todd Barton, Claudia A Kroker-Bode, Alvin Calderon, Catherine Apaloo, Amy W. Shaheen

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.